Target Group Inc (OTC: CBDY) is a cannabis company that operates a cultivation business, with principal offices located in Simcoe, Ontario, Canada. Revenue is generated through the sale of cannabis products, with inventory consisting of finished goods and work-in-process valued using an average cost methodology that incorporates direct labor, materials, and overhead costs (per 10-K filed 2026-03-31). The company has entered into distribution, collaboration, licensing, and sales agency agreements with cannabis-related parties including Canary Rx Inc., Serious Seeds B.V., Cannavolve Inc., and cGreen Inc. The balance sheet as of December 31, 2025 reflects a stockholders' deficiency position, and the company has financed operations in part through convertible promissory notes. As of March 31, 2026, there were 617,025,999 shares of common stock issued and outstanding. Anthony Zarcone serves as Chief Executive Officer and Director.

Revenue model

Product sales from cannabis cultivation, with deferred revenue present on the balance sheet as of December 31, 2025. The company has also entered into licensing and distribution agreements, suggesting royalty or fee-based revenue streams, though specific segment revenue figures are not disclosed in the filing excerpts.

Products and services

Cannabis cultivation products including finished goods and work-in-process inventory. The company has licensing agreements related to cannabis strains and cultivation technology, including arrangements with Serious Seeds B.V., cGreen Inc., and CannaKorp Inc. (per agreements referenced in 10-K filed 2026-03-31).

Customers and end markets

Cannabis end market, operating primarily in Canada. The filing references potential future operations in the United States. No specific customer concentration data is disclosed in the filing excerpts.

Value-chain role

Cannabis cultivator and licensor. The company grows cannabis, sells finished product, and licenses cultivation-related intellectual property through third-party agreements. It also acts as a distribution and collaboration partner via agreements with licensed producers and processors.

Geographic exposure

Canada (primary operations, Simcoe, Ontario headquarters). United States referenced as a potential future market in the 10-K filed 2026-03-31.

Source: SEC 10-K, filed 2026-03-31

Industry: Medicinal Chemicals & Botanical Products Peers: Pharmagreen Biotech Inc InMed Pharmaceuticals Inc